Inhibition of NA+/H+ Exchanger 1 Attenuates Renal Dysfunction Induced by Advanced Glycation End Products in Rats

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Li, Peng ^a,b   Chen, Geng Rong ^b   Wang, Fu ^c   Xu, Ping ^a   Liu, Li Ying ^a,b   Yin, Ya Ling ^a   Wang, Shuang Xi ^a,c  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARIPORIDE; CREATININE; GLUCOSE; GLUTATHIONE; LACTATE DEHYDROGENASE; MALONALDEHYDE; SODIUM PROTON EXCHANGE PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; SODIUM PROTON EXCHANGE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOWN REGULATION; DRUG EFFECT; EX VIVO STUDY; GENE EXPRESSION; GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CORTEX; KIDNEY DYSFUNCTION; KIDNEY HYPERTROPHY; MALE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; QUANTITATIVE ANALYSIS; RAT; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; KIDNEY; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; GLYCOSYLATION END PRODUCTS, ADVANCED; KIDNEY; L-LACTATE DEHYDROGENASE; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SODIUM-HYDROGEN ANTIPORTER;

EID: 84949996614     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/1802036     Document Type: Article

References (36)

1. V. P. Singh, A. Bali, N. Singh, and A. S. Jaggi, "Advanced glycation end products and diabetic complications, " The Korean Journal of Physiology and Pharmacology, vol. 18, no. 1, pp. 1-14, 2014.
2. S. Wang, Q. Peng, J. Zhang, and L. Liu, "Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain, " Cardiovascular Research, vol. 80, no. 2, pp. 255-262, 2008.
3. L. Counillon and J. Pouysségur, "The expanding family of eucaryoticNa+/H+ exchangers, "TheJournal of Biological Chemistry, vol. 275, no. 1, pp. 1-4, 2000.
4. M. Baumgartner, H. Patel, andD. L. Barber, "Na+/H+ exchanger NHE1 as plasmamembrane scaffoldinthe assemblyof signaling complexes, " American Journal of Physiology-Cell Physiology, vol. 287, no. 4, pp. C844-C850, 2004.
5. S.-X. Wang, L.-Y. Liu, Y.-H. Liu, and L.-Y. Liu, "Na+/H+ exchanger inhibitor prevented endothelial dysfunction induced by high glucose, " Journal of Cardiovascular Pharmacology, vol. 45, no. 6, pp. 586-590, 2005.
6. S.-X. Wang, X.-M. Xiong, T. Song, and L.-Y. Liu, "Protective effects of cariporide on endothelial dysfunction induced by high glucose, " Acta Pharmacologica Sinica, vol. 26, no. 3, pp. 329-333, 2005.
7. S. X. Wang, X. Y. Sun, X. H. Zhang, S. X. Chen, Y. H. Liu, and L. Y. Liu, "Cariporide inhibits high glucose-mediated adhesion of monocyte-endothelial cell and expression of intercellular adhesion molecule-1, " Life Sciences, vol. 79, no. 14, pp. 1399-1404, 2006.
8. D. Hileeto, M. Cukiernik, S. Mukherjee et al., "Contributions of endothelin-1 and sodium hydrogen exchanger-1 in the diabetic myocardium, " Diabetes/Metabolism Research and Reviews, vol. 18, no. 5, pp. 386-394, 2002.
9. M. Cukiernik, D. Hileeto, D. Downey et al., "The role of the sodium hydrogen exchanger-1 in mediating diabetes-induced changes in the retina, " Diabetes/Metabolism Research and Reviews, vol. 20, no. 1, pp. 61-71, 2004.
10. K. Takenaka, S.-I. Yamagishi, T. Matsui, K. Nakamura, and T. Imaizumi, "Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes, " Current Neurovascular Research, vol. 3, no. 1, pp. 73-77, 2006.
11. S.-I. Yamagishi, S. Ueda, and S. Okuda, "Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders, " Current Pharmaceutical Design, vol. 13, no. 27, pp. 2832-2836, 2007.
12. T. Sato, M. Iwaki, N. Shimogaito, X. Wu, S.-I. Yamagishi, andM. Takeuchi, "TAGE (Toxic AGEs) theory in diabetic complications, " Current Molecular Medicine, vol. 6, no. 3, pp. 351-358, 2006.
13. W. Koren, R. Koldanov, V. S. Pronin et al., "Enhanced erythrocyteNa +/H+ exchange predicts diabetic nephropathy in patients with IDDM, " Diabetologia, vol. 41, no. 2, pp. 201-205, 1998.
14. S. Wu, T. Song, S. Zhou et al., "Involvement of Na+/H+ exchanger 1 in advanced glycation end products-induced proliferation of vascular smooth muscle cell, " Biochemical and Biophysical Research Communications, vol. 375, no. 3, pp. 384-389, 2008.
15. R. C. Harmon, M. V. Terneus, K. K. Kiningham, and M. Valentovic, "Time-dependent effect of p-aminophenol (PAP) toxicity in renal slices and development of oxidative stress, " Toxicology and Applied Pharmacology, vol. 209, no. 1, pp. 86-94, 2005.
16. D. Gong, J. Lu, X. Chen et al., "A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-activation in the kidneys of rats used as a model of diabetes, " Diabetologia, vol. 51, no. 9, pp. 1741-1751, 2008.
17. L. J. He, M. Liang, F. F. Hou, Z. J. Guo, D. Xie, and X. Zhang, "Ethanol extraction of Picrorhiza scrophulariiflora prevents renal injury in experimental diabetes via anti-inflammation action, " Journal of Endocrinology, vol. 200, no. 3, pp. 347-355, 2009.
18. X.-H. Yang, P. Li, Y.-L. Yin et al., "Rosiglitazone via PPAR-dependent suppression of oxidative stress attenuates endothelial dysfunction in rats fed homocysteine thiolactone, " Journal of Cellular and Molecular Medicine, vol. 19, pp. 826-835, 2015.
19. S. Wang, C. Zhang, M. Zhang et al., "Activation of AMPactivated protein kinase alpha2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo, " Nature Medicine, vol. 18, no. 6, pp. 902-910, 2012.
20. K. Ienaga, C. H. Park, and T. Yokozawa, "Protective effect of an intrinsic antioxidant, HMH (5-hydroxy-1-methylhydantoin; NZ-419), against cellular damage of kidney tubules, " Experimental and Toxicologic Pathology, vol. 65, no. 5, pp. 559-566, 2013.
21. S. Harguindey, J. L. Arranz, J. D. Polo Orozco et al., "Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs-an integralmolecular/biochemical/ metabolic/clinical approach after one hundred years of cancer research, " Journal of Translational Medicine, vol. 11, article 282, 2013.
22. S. M. Qadri, Y. Su, F. S. Cayabyab, and L. Liu, "Endothelial Na+/H+ exchanger NHE1 participates in redox-sensitive leukocyte recruitment triggered by methylglyoxal, " Cardiovascular Diabetology, vol. 13, article 134, 2014.
23. V. Prasad, J. N. Lorenz, M. L. Miller et al., "Loss ofNHE1 activity leads to reduced oxidative stress in heart and mitigates highfat diet-induced myocardial stress, " Journal of Molecular and Cellular Cardiology, vol. 65, pp. 33-42, 2013.
24. S. Wang, M. Zhang, B. Liang et al., "AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes, " Circulation Research, vol. 106, no. 6, pp. 1117-1128, 2010.
25. P. Kang, C. Tian, and C. Jia, "Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy, " Gene, vol. 500, no. 1, pp. 1-9, 2012.
26. M. Murphy, F. Hickey, and C. Godson, "IHG-1 amplifies TGFbeta1 signalling and mitochondrial biogenesis and is increased in diabetic kidney disease, " Current Opinion in Nephrology and Hypertension, vol. 22, no. 1, pp. 77-84, 2013.
27. N. Ahmed, "Advanced glycation endproducts-role in pathology of diabetic complications, " Diabetes Research and Clinical Practice, vol. 67, no. 1, pp. 3-21, 2005.
28. O. Hori, S. D. Yan, S. Ogawa et al., "The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus, " Nephrology Dialysis Transplantation, vol. 11, no. 5, pp. 13-16, 1996.
29. G. Jerums, S. Panagiotopoulos, J. Forbes, T. Osicka, and M. Cooper, "Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease, " Archives of Biochemistry and Biophysics, vol. 419, no. 1, pp. 55-62, 2003.
30. R. Nagai, J.-I. Shirakawa, R.-I. Ohno, N. Moroishi, and M. Nagai, "Inhibition of AGEs formation by natural products, " Amino Acids, vol. 46, no. 2, pp. 261-266, 2014.
31. M. T. Coughlan, J. M. Forbes, and M. E. Cooper, "Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes, " Kidney international Supplement, no. 106, pp. S54-S60, 2007.
32. A. Gugliucci and T. Menini, "The axis AGE-RAGE-soluble RAGE and oxidative stress in chronic kidney disease, " Advances in Experimental Medicine and Biology, vol. 824, pp. 191-208, 2014.
33. S. X. Wang, L. Y. Liu, M. Hu et al., "Na+/H+ exchanger inhibitor prevented endothelial dysfunction inducedby high glucose, " Journal of Cardiovascular Pharmacology, vol. 45, pp. 586-590, 2005.
34. M. Avkiran and R. S. Haworth, "Regulatory effects ofGproteincoupled receptors on cardiac sarcolemmal Na+/H+ exchanger activity: signalling and significance, " Cardiovascular Research, vol. 57, no. 4, pp. 942-952, 2003.
35. S. M. Twigg, A. H. Joly, M. M. Chen et al., "Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts, " Endocrinology, vol. 143, no. 4, pp. 1260-1269, 2002.
36. K. Sharma and F. N. Ziyadeh, "Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-as a key mediator, " Diabetes, vol. 44, no. 10, pp. 1139-1146, 1995.